Leadership and Governance

The Biomarkers Consortium brings together various partners to identify, develop and qualify potential biomarkers to improve drug development and regulatory decision-making.

The Biomarkers Consortium’s Cancer, Inflammation & Immunity, Metabolic Disorders and Neuroscience Steering Committees are responsible for identifying and moving forward promising pre-competitive biomarkers projects for implementation by the Biomarkers Consortium, as well as overseeing each individual project under its purview.

The members of each Steering Committee represent a variety of sectors, including academia, government, industry and not-for-profit/advocacy organizations, and are led by two co-chairs representing two of the following three sectors: academia, government or industry.

Cancer Steering Committee

  • Gary Kelloff, M.D., NIH/NCI, (Co-Chair)
  • Eric Rubin, M.D., Merck (Co-Chair)
  • Amit Agarwal, M.D., Ph.D., Bristol-Meyers Squibb
  • Alexandre Akoulitchev, Ph.D., Oxford Biodynamics
  • Daniel Auclair, Ph.D., The Multiple Myeloma Research Foundation
  • Michelle Berny-Lang, Ph.D., NCI
  • Donald A. Berry, Ph.D., MD Anderson Cancer Center
  • Anahita Bhathena, Ph.D., AbbVie
  • Jonathan Blackburn, Ph.D., Sengenics
  • Anita Boyapati, Ph.D., Regeneron
  • Lisa Butterfield, Ph.D., PICI
  • Claudio Carini, Ph.D. Kings College London
  • Steven Cole, NCI
  • Cecile Combeau, Ph.D., Sanofi
  • Adam Corner, BioRad
  • Craig Cummings, Ph.D., Genentech
  • Emmanuelle di Tomaso, Ph.D., Bayer
  • Michelle Douglas, Ph.D., Genentech
  • Donna Flesher, Ph.D., Amgen
  • Steven Gendreau, Ph.D., Genentech
  • Ida Grundberg, Ph.D., Olink
  • Alexander R. Guimaraes, M.D. Ph.D., OHSU (QIBA-RSNA)
  • Stanley R. Hamilton, M.D., City of Hope National Medical Center
  • Sean Hanlon, Ph.D., NCI
  • Lyndsay Harris, M.D., NCI
  • Steffan Ho, M.D., Ph.D., Pfizer
  • Sung Jin Huh, Ph.D., Alkermes
  • Natalie Hutnick, Ph.D., Janssen
  • Rob Iannone, M.D., Jazz Pharmaceuticals
  • Peter Intile, SITC
  • John Jessup, M.D.
  • Morten Karsdal, Ph.D., Nordic Bioscience
  • Ilan (Lanny) Kirsch, M.D., Adaptive Biotechnologies
  • Tracy Lively, Ph.D., NIH/NCI
  • Daniel Maslyar, M.D., Alector
  • Robert McCormack, Ph.D.
  • Jen Mills, Ph.D., Foundation Medicine
  • Mike Montalto, Ph.D., PathAI
  • Helen Moore, Ph.D., NIH/NCI
  • Larry Nagahara, Ph.D., John’s Hopkins University
  • Michael O’Neal, M.D., BioClinica, Inc.
  • Geoff Oxnard, M.D., Foundation Medicine
  • Snehal Patel, Ph.D., Association for Molecular Pathology
  • Suso Platero, Ph.D., LabCorp
  • Vladimir Popov, Ph.D., FNLCR/NCI
  • Elizabeth Punnoose, Ph.D., Genentech
  • Gregory Reaman, M.D., FDA/CDER
  • Henry Rodriguez, Ph.D., NIH/NCI
  • Marijana Rucevic, Ph.D., Olink Proteomics
  • Amy Kate Sasser, Ph.D., Genmab US, Inc.
  • Houssein Abdul Sater, M.D., NIH/NCI
  • Andrew E. Schade, M.D., Ph.D., Eli Lilly & Company
  • Julie Schneider Ph.D., FDA/OCE
  • Lawrence Schwartz, M.D., Columbia University
  • Maggie Scully, Ph.D.,Frederick Natl. Lab. For Cancer Research
  • Ellen V. Sigal, Ph.D., Friends of Cancer Research
  • Matthew Silva, Ph.D., Invicro
  • Emily Stevens, Ph.D., Seattle Genetics, Inc.
  • Magadelena Thurin, Ph.D., NIH/NCI
  • Raoul Tibes, M.D., Ph.D., AstraZeneca
  • Peter Ujhazy, M.D., Ph.D., NIH/NCI
  • Megann Vaughn, M.B.A., LabCorp
  • Tony Wagner, Ph.D., Jazz Pharmaceuticals
  • Yan Wang, Ph.D., Alkermes
  • Ilan Wapinski, Ph.D., PathAI
  • Christine Ward, Ph.D., Takeda Pharmaceuticals International, Inc.
  • Mike Ward, Ph.D., Alector
  • Lisa Williams, Ph.D., Foundation Medicine
  • Mickey Williams, Ph.D., NIH/NCI
  • Michelle Zhang, Ph.D., Ikena Oncology

Inflammation & Immunity Steering Committee

  • David Fox, M.D., University of Michigan (Co-Chair)
  • Carolyn Cuff, Ph.D., Janssen (Co-Chair)
  • Alexandre Akoulitchev, M.A., Ph.D., Oxford Biodynamics
  • Tony Aliprantis, M.D., Ph.D., Merck
  • Tara Altepeter, M.D., FDA/CDER 
  • Niyanna Barron, M.B.A., OLINK
  • Anne-Christine Bay-Jensen, Ph.D., Nordic Biosciences A/S
  • Chantal Bazenet, Ph.D., Neurimmune AG
  • Robert Benschop, Ph.D., Eli Lilly
  • Maria Bettinotti, Ph.D., Association of Molecular Pathology (AMP)
  • Jonathan Blackburn, Ph.D., Sengenics
  • Preethi Chander, Ph.D., NIDCR/NIH
  • Chao Jiang, Ph.D., NIAID/NIH
  • Kelly Chun, Ph.D., LabCorp
  • Sahar Dawisha, M.D., FDA/CDRH
  • Betty Diamond, Ph.D., Feinstein Institute
  • Renee Donahue, Ph.D., NIH/NCI
  • Tom Esch, Ph.D., NIAID/NIH
  • Thomas Fuerst, Ph.D., BioClinica
  • Heath Guay, Ph.D., AbbVie
  • Kathy Hammitt, M.A., Sjogren's Syndrome Foundation
  • Caren Heller, M.D., MBA, Crohn's & Colitis Foundation of America
  • Marty Hodge, Ph.D., Pfizer
  • Robert Iannone, M.D., Jazz Pharmaceuticals 
  • Kathy Jung, Ph.D.,  NIH/NIAA
  • Ritu Kapur, Ph.D., Verily Life Sciences
  • Ernst Kriehuber, M.D., UCB
  • Mike Montalto, Ph.D., PathAI
  • Afsaneh Mozaffarian, PhD, Gilead
  • Daniel Maslyar, M.D., Alector
  • Bruce McManus, M.D., Ph.D., University of British Columbia
  • Nikolay Nikolov, M.D., FDA/CDER
  • Heiyoung Park, Ph.D., NIAMS/NIH
  • Jane Parnes, M.D., Amgen
  • Brian Porter, M.D., Ph.D., M.P.H., M.B.A., Novartis
  • Barbara Radziszewska, Ph.D., M.P.H., NIH/NIA
  • Saifur Rahman Ph.D., MBA, Frederick National Lab for Cancer Research 
  • Deepak Rajpal, Ph.D., Sanofi
  • John Reveille, M.D., University of Texas Health Science Center (Houston)
  • Lisa Rider, M.D., NIH/NIEHS
  • Jane Salmon, M.D., Hospital for Special Surgery
  • Susana A. Serrate-Sztein, M.D., NIH/NIAMS
  • Matthew Silva, Ph.D., Invicro
  • Glennda Smithson, Ph.D., Takeda
  • Lisa Spain, Ph.D., NIH / NIDDK;
  • Paresh Thakker, Ph.D., Regeneron
  • Maria Vassileva, Ph.D., Arthritis Foundation
  • Sudha Visvanathan, Ph.D., Boehringer Ingelheim
  • Andrea Wagenfeld, Ph.D., Bayer
  • Michael Weisman, M.D., Cedars-Sinai Medical Center
  • Michael Whitfield, Ph.D., Dartmouth Geisel School of Medicine

Metabolic Disorders Steering Committee

  • Ellen Leschek, M.D., NIH/NIDDK (Co-Chair)
  • Roberto Calle, M.D., Pfizer (Co-Chair)
  • Stan Belkowski, Ph.D., Janssen
  • Javed Butler, MD, University of Mississippi
  • Oscar Carrasco-Zevallos, PhD, Path AI
  • Lara Dimick, MD, FDA
  • Samuel Engel, M.D., Merck
  • Klaus Engelke, Ph.D., BioClinica
  • Mike Espey, PhD, NCI
  • Christian Friedrich, Bayer
  • Chris Hartshorn, PhD, NCI
  • Claude Hughes, M.D., Ph.D., Quintiles
  • Lyndon Joseph, Ph.D., NIH/NIA
  • Satya Karnik, Ph.D., Regeneron
  • Morten Karsdal, Ph.D., M.Sc., mMBA, Nordic Bioscience A/S
  • Makoto Kashiwa, Ph.D., Astellas
  • Helina Kassahun, M.D., Amgen
  • Keith Kaufman, M.D., Merck
  • Young S. Kim, Ph.D., NIH/NCI
  • Kathy Landschulz, Ph.D., LabCorp
  • Olof Dahlqvist Leinhard, Ph.D., AMRA Medical
  • Maria Chiara Magnone, Ph.D., Janssen
  • Mike Montalto, Ph.D., PathAI
  • Sven Moosmang, M.D., MPH, AstraZeneca
  • Afshin Parsa, M.D., MPH, NIH/NIDDK
  • Aaron Pawlyk, PhD, NCHID
  • Ilan Rabiner, Ph.D., Invicro
  • Sven Reimann, Ph.D., Bayer
  • Vandana Sachdev, M.D., NIH/NHLBI
  • Anthony Samir M.D., MGH
  • Arun Sanyal, M.D., VCU
  • Sudha Shankar, M.D., AstraZeneca
  • Matthew Silva, Ph.D., Invicro
  • Glennda Smithson, Ph.D., Takeda
  • Pothur Srinivas, Ph.D., NIH/NHLBI
  • Elizabeth Stafford, Ph.D., FDA/CDRH
  • Melissa Thomas, M.D., Ph.D., Eli Lilly
  • Moises Torres-Gonzalez, Ph.D., National Dairy Council
  • Megann Vaughn, M.B.A., LabCorp
  • David R. Vera, Ph.D., University of California, San Diego
  • Tony Wagner, PhD, Jazz Pharmaceuticals
  • Mike Ward, Ph.D., Alector

Neuroscience Steering Committee

  • Linda Brady, Ph.D., NIH/NIMH (Co-Chair)
  • Hartmuth Kolb, Ph.D., Janssen (Co-Chair)
  • William Potter, M.D., Ph.D., NIH/NIMH (Co-Chair Emeritus)
  • Alexandre Akoulitchev, M.A., Ph.D., Oxford Biodynamics
  • Anthony Bannon, Ph.D., AbbVie
  • Daniel Barboriak, M.D., Radiological Society of North America
  • Wade Berrettini, M.D., Ph.D., UPenn
  • Nicole Bjorklund, Ph.D., Alzheimer's Drug Discovery Foundation
  • Jonathan Blackburn, Ph.D., MASSAf, Sengenics
  • Silvana Borges, M.D., FDA
  • Diane Bovenkamp, Ph.D., BrightFocus Foundation
  • Brian Campbell, Ph.D., Sage Therapeutics
  • Maria Carrillo, Ph.D., Alzheimer's Association
  • Susan Catalano, Ph.D., Cognition Therapeutics
  • Caroline Cohen, Ph.D., Sanofi
  • Susan Croll, Ph.D., Regeneron
  • Rebecca Edelmayer, Ph.D., Alzheimer's Association
  • Howard Fillit, M.D., Alzheimer's Drug Discovery Foundation
  • Thomas Finn, Ph.D., FDA
  • Bernard Fischer, M.D., FDA/CDER
  • Just Genius, M.D., UCB
  • Danielle Graham, Ph.D., Biogen 
  • Ida Grudenberg, Ph.D., Olink Proteomics
  • Lyn Jakeman, Ph.D., NINDS
  • Katherine Jung, Ph.D., NIH/NIAAA
  • Morten Karsdal, Ph.D., M.Sc., mMBA, Nordic Bioscience A/S
  • Johanne Kaplan, Ph.D., ProMIS Neurosciences
  • Walter J. Koroshetz, M.D., NIH/NINDS
  • James Kupiec, M.D., ProMIS Neurosciences
  • Frank Lebeda, Ph.D., US Military
  • Kristina Malzbender, Gates Ventures
  • Eliezer Masliah, Ph.D., NIH/NIA
  • Bradley Miller, M.D., Ph.D., Eli Lilly
  • David Millis, M.D., M.B.A., Ph.D., FDA/CDER
  • Laura Mitic, Ph.D., The Bluefield Project to Cure FTD
  • Jose Luis Molinuevo, M.D., Ph.D., Barcelona Beta Brain Research Center
  • Mike Montalto, Ph.D., PathAI
  • Prodromos Parasoglou, Ph.D., Regeneron
  • Rodney Pearlman, Ph.D., The Bluefield Project to Cure FTD
  • Mary Ann Pelleymounter, Ph.D., NIH/NINDS
  • Chris Petropoulos, LabCorp
  • Niels Plath, Ph.D., Lundbeck
  • Josh Porter, Olink Proteomics
  • Ilan Rabiner, M.D., Invicro
  • Kurt Rasmussen, Ph.D., NIH/NIDA
  • Sounder Regunathan, Ph.D., NIH/NIAAA
  • Cristina Sampaio, M.D., Ph.D., CHDI Foundation
  • Steve Sands, Ph.D., Amgen
  • Nina Schor, Ph.D., NIH/NINDS
  • Howard Schulman, Ph.D., Allosteros Therapeutics
  • Lamya Shihabuddin, Ph.D., Sanofi
  • Daniel Smith, Ph.D., Alkermes
  • Sean Smith, Ph.D., Merck
  • Arie Struyk, M.D., Ph.D., Merck
  • Joyce Suhy, Ph.D., BioClinica
  • Nadine Tatton, Ph.D., The Association for Frontotemporal Degeneration
  • Johannes Tauscher, M.D., Takeda
  • Chris Turck, Ph.D., Max Planck Institute of Psychiatry
  • Eugeen Vanmechelen, Ph.D., ADx Neurosciences
  • Michael Ward, Ph.D., Alector
  • Chris Weber, Ph.D., Alzheimer's Association
  • Stephen Wood, Amgen
  • Kevin Yarasheski, Ph.D., C2N Diagnositcs
  • Henrik Zetterberg, M.D., Ph.D., University of Gothenburg